The Liver Cancer Study Group of Japan analyzed 11, 916 patients with primary liver cancer diagnosed from Jan. 1, 1990 to Dec. 31, 1991 in 536 hospitals throughout the country. They comprised 11379 cases of hepatocellular carcinoma, 322 of cholangiocellular carcinoma, 24 of cystadenocarcinoma, 30 of mixed carcinoma, 8 of hepatoblastoma and 7 of sarcoma in clinical diagnosis. This article revealed the current status of primary liver cancer in Japan, particularly, that of hepatocellular carcinoma (HCC) and cholangiocellular carcinoma (CCC) in the aspects of the epidemiology and the clinicopathological features. The survival rates of the HCC patients who received hepatic resection, transarterial embolization (TAE), and percutaneous ethanol injection (PEI) were calculated based on follow-up from Jan. 1, 1978 to Dec. 31, 1991. Three year-and five year-survival rates of the patients who underwent hepatic resection were 57.5% and 40.8%, respectively, and those of TAE were 19.5% and 8.0% respectively. Three year-survival rate of the patients with PEI was 53.2%.
Furthermore, Cox's multivariate analysis and the stepwise method were performed to determine significant prognostic variables and to investigate the appropriate combination of these variables for predicting prognosis.
View full abstract